Publications

Books & Edited Volumes

  1. Pavadai, P. (Ed.). (2026). Decoding Breast Cancer: Molecular Pathways and Emerging Therapeutic Strategies. Bentham Books Publisher.
  2. Pavadai, P. (Ed.). (2026). Cancer Management Through Endophyte Metabolites: From discovery to delivery.(Upcoming release) Springer Nature Publisher.

Peer-Reviewed Journal Articles
[Publications in Scopus / SCI Indexed Journals (*Corresponding author)]

  1. Nandini Markuli Sadashivappa, Basavana Gowda Hosur Dinesh, Sandra Ross Olakkengil Shajan, Sunil Kumar Bandral, Srinivas Ganjipete, Devaraj Hanumanthappa, Shivaraj Kumar Walikar, Prabu Kumar Seetharaman, Mohankumar Ramar, Selvaraj Kunjiappan, Paruvathanahalli Siddalingam Rajinikanth, Damodar Nayak Ammunje and Parasuraman Pavadai*. Chk1-Targeted Hesperidin Liposomes for Breast Cancer Therapy: An Integrated In Silico, In Vitro, and In Vivo Evaluation. ACS Applied Bio Materials. (ACS publisher – IF: 4.7). View Publication (DOI)
  2. Zakiya Fathima C., Jainey P. James, Srinivas Ganjipete, Parasuraman Pavadai, Sindhu T. J. Rational Design of Pyrazole–Chalcone Congeners via Enumeration: Insights From Molecular Docking, MM-GBSA, Pharmacophore Modelling, MD Simulations and DFT Calculations. Journal of Chemistry. (Wiley Publisher – IF 2.6). View Publication (DOI)
  3. Stalin Arulsamy, Praveen Jambulingam Mani, Sivakumar Ravi, Thulasidass Govindasamy, Thiruppanesh Selvam, Mohankumar Ramar, Logesh Rajan, Suresh Kumar Krishnan, Gayathri Rajaram, Kiruthiga Natarajan, Parasuraman Pavadai*. Machine Learning-Driven Discovery of Marine-Derived LasR Inhibitors on Pseudomonas aeruginosa to Combat Antimicrobial Resistance. Journal of the Indian Chemical Society. (Elsevier publisher - IF: 3.3). View Publication (DOI)
  4. Shanmugampillai Jeyarajaguru Kabilan, Selvaraj Kunjiappan, and Parasuraman Pavadai. Phytochemical Profiling and In Silico Targeting of Krüppel-Like Factors 4 (KLF4) by Orthosiphon stamineus for CKD Intervention. Journal of Computational Biophysics and Chemistry. (World Scientific Publishing - IF: 2.2). View Publication (DOI)
  5. Selvaraj Kunjiappan, Madasamy Sundar, Venkataswamy Parvathi, Parasuraman Pavadai, Bandral Sunil Kumar, Ponnusamy Palanisamy, Jeganpandi Senthamarai Pandi. Identification of potential Phosphodiesterase 1 inhibitors from plant phytochemicals for the treatment of cognitive impairment using molecular modeling tools. Journal of Computational Biophysics and Chemistry. (World Scientific Publishing - IF: 2.2). View Publication (DOI)
  6. Kunal Agam Kanaujia, Dilip Kumar Arya, Anit Kumar, Shubham Kanaujiya, Prashant Pandey, Srinivas Ganjipete, Shubhini A. Saraf, Parasuraman Pavadai and P. S. Rajinikanth. Bioinspired antimicrobial peptide hydrogel dressing for the accelerated healing of infected wounds. Journal of Materials Chemistry B. (RSC Publisher - IF: 5.8). View Publication (DOI)
  7. Basavana Gowda Hosur Dinesh, Srinivas Ganjipete, Bandral Sunil Kumar, Damodar Nayak Ammunje, Selvaraj Kunjiappan, Prabu Kumar Seetharaman, Mohankumar Ramar, Kumarappan Chidambaram & Parasuraman Pavadai*. Machine learning-driven drug repurposing for HER2-positive breast cancer. Scientific Reports. (Nature Publisher – IF: 3.9). View Publication (DOI)
  8. Santosh Kumar, Md Meraj Anjum, Dilip Kumar Arya, Anit Kumar, Shubham Kanaujiya, Kunal Agam Kanaujia, Prashant Pandey, Mohankumar Ramar, Saurabh Srivastava, Parasuraman Pavadai & P. S. Rajinikanth. Hierarchical Surface-Engineered Biomimetic PLGA Nanoparticles for Targeted Pulmonary Delivery of Lumacaftor in Cystic Fibrosis. BioNanoScience. (Springer Nature Publisher – IF: 3.2). View Publication (DOI)
  9. Selvaraj Kunjiappan, Murugesan Sankaranarayanan, Pavadai Parasuraman. Sialic Acid-Receptor Targeted Epirubicin and Naringin-Loaded Sialic Acid-Conjugated Silk Fibroin Nanoparticles for Enhanced Lung Cancer Treatment. Journal of Polymers and the Environment. (Springer Nature Publisher – IF: 5.0). View Publication (DOI)
  10. Chetan Ashok, Srikanth Jeyabalan, Parasuraman Pavadai, Vignesh M, Devaraja Dravida Pandiyan S, Durga Mohan, Revathi Sugumar, Ramya Sugumar, Sugin Lal Jabaris, Vetriselvan Subramaniyan, Ling Shing Wong, Mahendran Sekar. Methoxylated Flavonoids in Parkinson's Disease: Insights from Network Pharmacology and Molecular Dynamics. Toxicology Reports. (Elsevier publisher - IF: 0.7). View Publication (DOI)
  11. Stalin Arulsamy, Kiruthiga Natarajan, Mohankumar Ramar, Parasuraman Pavadai*. Universal molecular fingerprint highlighter: An interactive visualization platform for explainable cheminformatics and QSAR model interpretation. In Silico Research in Biomedicine. (Elsevier publisher - IF: 0.3). View Publication (DOI)
  12. Bandral Sunil Kumar, Basavana Gowda Hosur Dinesh, Srinivas Ganjipete, Mohankumar Ramar, Sankaranarayanan Murugesan, Damodar Nayak Ammunje, Selvaraj Kunjiappan, Parasuraman Pavadai*. Therapeutic Potential of Morin in Alzheimer's Disease: An Integrated Network Pharmacology, Molecular Docking, ADMET, and Molecular Dynamics Study. ChemistrySelect. (Wiley Publisher - IF 2). View Publication (DOI)
  13. Jeganpandi Senthamarai Pandi, Parasuraman Pavadai, Panneerselvam Theivendren, Murugesan Sankaranarayanan and Selvaraj Kunjiappan. Enhanced anticancer activity of Naringenin-encapsulated poly (lactic acid)/Neem gum nanoparticles for breast cancer cells. Biomedical Materials. (IOP Publishers- IF: 3.7). View Publication (DOI)
  14. Niranjana Devi Rajendran, Arulraj Ramalingam, Justin Prabakaran, Ronaldo Anuf, Srinivas Ganjipete, Parasuraman Pavadai. Theoretical insights into the reactivity, topological properties, and OSR1 kinase interaction of anti-hypertensive drugs: a DFT and docking-based study. Discover Chemistry. (Springer Nature - IF: N/A). View Publication (DOI)
  15. Bandral Sunil Kumar, Basavana Gowda Hosur Dinesh, Srinivas Ganjipete, Mohankumar Ramar, Damodar Nayak Ammunje, Selvaraj Kunjiappan, Kumarappan Chidambaram & Parasuraman Pavadai*. Machine learning guided virtual screening of FDA approved drugs targeting GSK-3β in Alzheimer's disease. Scientific Reports. (Nature Publisher - IF: 3.8). View Publication (DOI)
  16. Jeganpandi Senthamarai Pandi, Parasuraman Pavadai, Ewa Babkiewicz, Theivendren Panneerselvam, Piotr Maszczyk, Murugesan Sankaranarayanan, Mohankumar Ramar, Selvaraj Kunjiappan. Targeted Delivery of Thymoquinone-Encapsulated Polyethyleneimine/Poly (Lactic Acid) Nanoparticles Into Breast Cancer Cells. Drug Development Research. (Wiley Publisher - IF 4.2). View Publication (DOI)
  17. Srinivas Ganjipete, Basavana Gowda Hosur Dinesh, Sunil Kumar Bandral, Mohankumar Ramar, Damodar Nayak Ammunje, Parasuraman Pavadai*. Nutraceuticals in breast cancer therapy: Mechanistic insights and therapeutic potential. International Journal of Biological Macromolecules. (Elsevier publisher - IF: 8.5). View Publication (DOI)
  18. Venkatesh Subbiah, Jegathalaprathaban Rajesh, Wubshet Mekonnen Girma, Parasuraman Pavadai, Surulivel Gokul Eswaran, Thavuduraj Kavitha, A Santhana Krishna Kumar. Magnetic nanoparticles‐decorated zeolite thin film derived from coal fly ash: Application to detoxification of para‐nitrophenol. Journal of the Chinese Chemical Society, 1-16. (Wiley Publisher - IF 1.5). View Publication (DOI)
  19. Stalin Arulsamy, Mohankumar Ramar, Kartiga Natarajan, Kiruthiga Natarajan, Suresh Kumar Krishnan,Parasuraman Pavadai*. Marine bioactive molecules as potential antiviral agents against HMPV key proteins: An integrated Machine Learning based in-silico approach. Journal of the Indian Chemical Society. (Elsevier publisher - IF: 3.3). View Publication (DOI)
  20. Ragavendhar Gopinath, Chetan Ashok, Naveen Kumar Rajasekaran, Mahendran Sekar, Parasuraman Pavadai, Wong Ling Shing, Vetriselvan Subramaniyan, Srikanth Jeyabalan. Computational Discovery of the Neuroprotective Potential of Karanjin Against Parkinson's Disease. ChemistrySelect. (Wiley Publisher - IF 2). View Publication (DOI)
  21. Devaraj Hanumanthappa, Bandral Sunil Kumar, Sandra Ross Olakkengil Shajan, et al., & Parasuraman Pavadai*. Computational insights and experimental breakthroughs in identifying Next-generation Acetylcholinesterase inhibitors. Scientific Reports, 31901:2025, 15;31901:2025. (Nature Publisher - IF: 3.8). View Publication (DOI)
  22. Lim Joe Siang, Kamini Vijeepallam, Arunachalam Muthuraman, Parasuraman Pavadai, et al. Exploration of Canarium odontophyllum fruit phytoconstituents as potential candidates against epilepsy using in silico studies. Journal of Genetic Engineering and Biotechnology. (Elsevier publisher - IF: 3.6). View Publication (DOI)
  23. Chandrasekar Palanichamy, Parasuraman Pavadai, Panneerselvam Theivendren, et al. Identification of potential antidiabetic inhibitor from Mimosa pudica Linn. through in silico molecular modeling and DFT tools. Journal of Research in Pharmacy. (Scopus Indexed). View Publication (DOI)
  24. Sandra Ross Olakkengil Shajan, Shivaraj Kumar Walikar, Nandini Markuli Sadashivappa, et al., & Parasuraman Pavadai*. Folic Acid-Conjugated Ferulic Acid-Entangled Single-Walled Carbon Nanotubes: A Targeted Therapeutic Approach for Effective Breast Cancer Treatment. Journal of Drug Delivery Science and Technology. (Elsevier publisher - IF: 4.5). View Publication (DOI)
  25. Kabilan, S. J., Kunjiappan, S., Pavadai, P., et al. "Pharmaco-informatics screening of Zingiber officinale biomolecules targeting FOXO6 for chronic kidney disease therapy". Drug Metabolism and Personalized Therapy. (De Gruyter Brill - IF-1). View Publication (DOI)
  26. Panneerselvam Theivendren, Parasuraman Pavadai, Suganthan Veerachamy, et al. Surface receptor-targeted protein-based nanocarriers for drug delivery: advances in cancer therapy. Nanotechnology. (IOP Publishers- IF: 2.9). View Publication (DOI)
  27. Panneerselvam Theivendren, Parasuraman Pavadai*, Selvaraj Kunjiappan, et al. Emerging therapeutic strategies and opportunities in targeting protein pathways for breast cancer treatment: a critical review. Nanotechnology. (IOP Publishers- IF: 2.9). View Publication (DOI)
  28. Panneerselvam Theivendren, Selvaraj Kunjiappan, Parasuraman Pavadai, et al. Development of Nipah virus drugs from FDA-approved drugs: An integrated computational approach. Computational Toxicology. (Elsevier publisher - IF: 3.1). View Publication (DOI)
  29. Uthirapathi Logeswari Rakesh, Golla Anil Kumar, Theivendren Panneerselvam, Parasuraman Pavadai, et al. Computational Discovery of Plant-Derived Flavonoids as Potential Amyloid-β Fibril Disaggregating Agents for Alzheimer’s Disease. Brain Disorders. (Elsevier publisher - Scopus Indexed). View Publication (DOI)
  30. Tincy Biju, Chidananda Venkatesh, Darshana Ballagere Honnasiddappa, et al., & Parasuraman Pavadai*. ATAD2 bromodomain in cancer therapy: current status and future perspectives. International Journal of Biological Macromolecules. (Elsevier publisher - IF: 8.5). View Publication (DOI)
  31. Shannon D Almeida, Sameera Hammigi Ramesh, Govardhan Katta Radhakrishna, et al., & Parasuraman Pavadai*. Development and evaluation of S-carboxymethyl-L-cystine-loaded solid lipid nanoparticles for Parkinson’s disease in murine and zebrafish models. Scientific Reports, 15:10885, 2025. (Nature Publisher - IF: 3.8). View Publication (DOI)
  32. Jithu Jerin James, KV Sandhya, Parasuraman Pavadai, et al. Exploring Placental Protein-Target Protein Interactions: In Silico and In Vitro Approaches for Osteoarthritis Therapy. Current protein & peptide science. (Bentham Science Publishers - IF: 1.9). View Publication (DOI)
  33. Athavan Alias Anand Selvam, Sunil Kumar Bandral, Parasuraman Pavadai, et al. Computational identification and molecular characterization of novel Aurora-B kinase inhibitors: Pharmacophore modeling, docking, and molecular dynamics simulations. Innovative Medicines & Omics 6547. (SCOPUS INDEXED). View Publication (DOI)
  34. Basavana Gowda Hosur Dinesh, Bandral Sunil Kumar, Nandini Markuli Sadashivappa, et al., & Parasuraman Pavadai*. Targeting the PI3K Pathway: Advancements and Achievements in Breast Cancer Therapy. Current Pharmaceutical Design. (Bentham Science Publishers - IF: 2.6). View Publication (DOI)
  35. Keerthana Nagarajan, Mahisha Devi Chelladurai, Sivaranjini Mani, Parasuraman Pavadai, et al. Unlocking Antidiabetic Potential: Novel Compounds from Endophytic Fungi Isolated from Manihot esculenta Crantz Tuberous Roots. Journal of Molecular Structure. View Publication (DOI)
  36. Arunkumar Manoharan, Panneerselvam Theivendren, Maya Sharma, Selvaraj Kunjiappan, Saravanan Govindaraj & Parasuraman Pavadai. Design, molecular modelling, synthesis, characterization studies of novel N-(7-(substituted benzylidene)-4-phenyl-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-2-yl)-1-(substituted phenyl)methanimine against breast cancer. Journal of the Iranian Chemical Society. (Springer Nature Publisher - IF: 2.2). View Publication (DOI)
  37. Ravichandran Veerasamy, Raghuraman Seenivasan, Harish Rajak, Parasuraman Pavadai, et al. Mushroom Derived Compounds Unveiled Naringin as A Potential Multi-Targeted Anti-Breast Cancer Compound - An In-Silico Approach. Journal of Faculty of Pharmacy of Ankara University, 49(1):21-4. (SCOPUS INDEXED). View Publication (DOI)
  38. Ravichandran Veerasamy, Raghuraman Seenivasa, Prabha Thangavelu, Harish Rajak, Parasuraman Pavadai. In Silico Docking, Drug-likeness and Toxicity Prediction Studies of Bioactive Compounds of Eurycoma longifolia as Potential Multi-targeted Antiviral Agents against SARS-CoV-2. Moroccan Journal of Chemistry, 13(1); 381. (SCOPUS INDEXED). View Publication (DOI)
  39. Jeganpandi Senthamarai Pandi, Parasuraman Pavadai, Lakshmi M. Sundar, et al. Pharmacokinetics and Brain Tumor Delivery Studies of Thymoquinone- Encapsulated Eudragit L100-Coated Solid-Lipid Nanoparticles. Journal of Cluster Science, 36(1): 26. (Springer Nature Publisher - IF: 2.7). View Publication (DOI)
  40. Subramanian Haripriya, Muniyandi Vijayalakshmi, Chandu Ala, Sankaranarayanan Murugesan, Parasuraman Pavadai, et al. Pharmacoinformatics-based prediction of Checkpoint Kinase-1 inhibitors from Momordica charantia Linn. for cancer. Computational Biology and Chemistry. View Publication (DOI)
  41. Sandra Ross Olakkengil Shajan, Nandini Markuli Sadashivappa, Devaraj Hanumanthappa, et al., & Parasuraman Pavadai*. Exploring the Potential Application of Single-Walled Carbon Nanotubes in Medical Treatment and Therapy. Talanta Open. View Publication (DOI)
  42. Panneerselvam Theivendren, Selvaraj Kunjiappan, Parasuraman Pavadai, et al. Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy. ACS Measurement Science Au. (ACS publisher - IF: 4.6). View Publication (DOI)
  43. Bandral Sunil Kumar, Basavana Gowda Hosur Dinesh, Sandra Ross Olakkengil Shajan, et al., & Parasuraman Pavadai*. Alzheimer's Disease Protein Targets: Comprehensive Review and Future Directions. Current Pharmaceutical Design. (Bentham Science Publishers - IF: 2.6). View Publication (DOI)
  44. Kunjiappan, S., Panneerselvam, T., Pavadai, P., Balakrishnan, V., Pandian, S. R. K., Palanisamy, P., Sankaranarayanan, M., Kabilan, S. J., Sundaram, G. A., Tseng, W., & Kumar, A. S. K. (2024). Fabrication of folic acid-conjugated pyrimidine-2(5H)-thione-encapsulated curdlan gum-PEGamine nanoparticles for folate receptor targeting breast cancer cells. International journal of biological macromolecules, 277(Pt 3), 134406. View Publication (DOI)
  45. Govardhan Katta Radhakrishna, Sameera Hammigi Ramesh, Shannon D Almeida, et al., & Parasuraman Pavadai*. Capsaicin-entangled Multi-walled Carbon Nanotubes against Breast cancer: A Theoretical and Experimental Approach. Journal of Cluster Science. (Springer Nature Publisher - IF: 2.7). View Publication (DOI)
  46. Raja Rajeswari Rajeshkumar, Theivendren Panneerselvam, Parasuraman Pavadai, et al. Folate Receptor-Targeted Camptothecin-Loaded PLGA-Glutenin Nanoparticles for Effective Breast cancer Treatment. Journal of Polymers and the Environment. (Springer Nature Publisher - IF: 4.7). View Publication (DOI)
  47. Govardhan Katta Radhakrishna, Damodar Nayak Ammunje, Selvaraj Kunjiappan, et al., & Parasuraman Pavadai*. A Comprehensive Review of Capsaicin and Its Role in Cancer Prevention and Treatment. Drug Research (Stuttg), 74(5):195-207. (Thieme Medical Publishers - IF: 2.2). View Publication (DOI)
  48. Selvaraj Kunjiappan, Lokesh Kumar Ramasamy, Suthendran Kannan, Parasuraman Pavadai, et al. Optimization of ultrasound-aided extraction of bioactive ingredients from Vitis vinifera seeds using RSM and ANFIS modeling with machine learning algorithm. Scientific Reports, 14:1219. (Nature Publisher - IF: 4.6). View Publication (DOI)
  49. Megha Krishnappa, Sindhu Abraham, Sharon Caroline Furtado, et al., & Parasuraman Pavadai*. An Integrated Computational and Experimental Approach to Formulate Tamanu Oil Bigels as Anti-Scarring Agent. Pharmaceuticals, 17(1):102. (MDPI- IF: 4.6). View Publication (DOI)
  50. Derina J. Pearlin Daniel, Shruthi Shanmugasundaram, Karunya Sri Chandra Mohan, et al., & Parasuraman Pavadai, et al. Elucidating the role of phytocompounds from Brassica oleracea var. italic (Broccoli) on hyperthyroidism: an in-silico approach. In Silico Pharmacology, 12:6. (SCOPUS INDEXED). View Publication (DOI)
  51. Chaithra R Shetty, C. S. Shastry, Parasuraman P, et al. Thiazolo-pyridopyrimidines: An in-silico evaluation as a lead for CDK4/6 inhibition, synthesis and cytotoxicity screening against breast cancer cell lines. Bioimpacts, 14(4): 29951. (Tabriz University of Medical Sciences - IF: 2.6). View Publication (DOI)
  52. Swaroopa HM, Parasuraman Pavadai*. Identification of Potential Inhibitors for Acetyl Cholinesterase Enzyme to Treat Alzheimer’s Disease: A Computational Approach. VVIJOURNAL, 11(14):193-211.
  53. Swaroopa HM, Parasuraman Pavadai*. Virtual Screening for Alzheimer's Therapy: Computational Identification of Acetylcholinesterase Inhibitors: A Computational Approach. VVIJOURNAL, 11(14):212-228.
  54. Shannon D Almeida, Akash Kumar Pandey, Mohamed Mutahir, et al., & Parasuraman Pavadai*. Drug Repurposing for Primary Lateral Sclerosis: A Molecular Dynamic Study. Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). (RSC Conference Proceedings, SCOPUS INDEXED). View Publication (DOI)
  55. Manisha Devi, Anbu Jayaraman, Parasuraman Pavadai, et al. Hit Identification from Ganoderma Lucidum to Treat Polycystic Ovarian Syndrome: An In-Silico Approach. Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). (RSC Conference Proceedings, SCOPUS INDEXED). View Publication (DOI)
  56. Judy Jays, P Parasuraman, J Saravanan. Screening of Some Novel Isoxazoles Against C. Albicans for their Potential Use as antifungals: A Computational Approach. Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). (RSC Conference Proceedings, SCOPUS INDEXED). View Publication (DOI)
  57. Jithu Jerin James, Parasuraman Pavadai, KV Sandhya. Screening of Placental Proteins Against Proteases for their Potential Use in Osteoarthritis: A Computational Approach. Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). (RSC Conference Proceedings, SCOPUS INDEXED). View Publication (DOI)
  58. Chandrasekar Palanichamy, Damodar Nayak Ammunje, Parasuraman Pavadai, et al. Mimosa pudica Linn. extract improves aphrodisiac performance in diabetes-induced male Wister rats. Journal of Biomolecular Structure and Dynamics. (Taylor and Francis - IF: 4.4). View Publication (DOI)
  59. Raja Rajeswari Rajeshkumar, Parasuraman Pavadai, Theivendren Panneerselvam, et al. Enhanced Delivery of Retinoic Acid to Breast Cancer Cells by Folate Receptor-Targeted Folic Acid-Conjugated Glutenin Nanoparticles for Promising Treatment of Breast Cancer. Journal of Polymers and the Environment. (Springer Nature publisher - IF: 5.3). View Publication (DOI)
  60. Soundarya Ramesh, Shannon D Almeida, Sameerana Hammigi, et al., & Parasuraman Pavadai*. A Review of PARP-1 Inhibitors: Assessing Emerging Prospects and Tailoring Therapeutic Strategies. Drug Research (Stuttg), 73(09): 491-505. View Publication (DOI)
  61. Deepthi NG, Thansha Seethamma, Saumya Priya, Keerthi R, Sonu Shifan P, Agasa Ramu Mahesh, Parasuraman Pavadai, et al. Repurposing of Drugs for The Treatment of Cystic Fibrosis: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12 [7] June 2023: 217-226.
  62. Mahasin K, Madhushree K, Devika M, Divya B, Agasa R M, Saravanan G, Suresh R, R. Sathish Adithya, Parasuraman P*. Discovery of Novel AKT2 Inhibitors for The Treatment of Breast Cancer: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[7] June 2023: 191-197.
  63. Divya B, Mahasin K, Madhushree K, Devika M, Agasa R M, Saravanan G, Suresh R, R. Sathish Adithya, Parasuraman P*. Pharmacophore Identification of Alternative HMG-CoA Reductase Inhibitor: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[7] June 2023: 186-190.
  64. Nayana R J, Bandral S K, Genne S, Golla S, Agasa R M, Selvaraj K, Theivendren P, R. Sathish Adithya, Parasuraman P*. Identification of Novel GABA-A Inhibitor for The Treatment Of Epilepsy: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[7] June 2023: 180-185.
  65. Golla S, Nayana R J, Bandral S K, Genne S, Agasa R M, Selvaraj K, Theivendren P, R. Sathish Adithya, Parasuraman P*. Identification of Novel Lead Moieties as Anti-Cholinesterase Agents: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[7] June 2023: 175-179.
  66. Genne S, Golla S, Nayana R J, Bandral S K, Agasa R M, Selvaraj K, Theivendren P, R. Sathish Adithya, Parasuraman P*. Identification of Novel Lead to Inhibit HIV Protease: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[6] May 2023: 209-215.
  67. Bandral S K, Genne S, Golla S, Nayana R J, Agasa R M, Selvaraj K, Theivendren P, S. Kanimozhi, Parasuraman P*. Identification of Potent Lead to Inhibit DHFR for the Treatment of Cancer: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[6] May 2023: 200-208.
  68. Madhushree K, Devika M, Divya B, Mahasin K, Radhika N, Agasa R M, Saravanan G, Suresh R, Goutam H, Parasuraman P*. Potent Lead Identification against Xanthine oxidase for the Treatment of Gout: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[6] May 2023: 194-199.
  69. Devika M, Divya B, Mahasin K, Madhushree K, Agasa R M, Saravanan G, Suresh R, Goutam H, Parasuraman P*. Potent Lead Identification for COX-2 Enzyme: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[6] May 2023:187-193.
  70. Basavana Gowda H D, Brundha S N, Srinivas G, Soundarya R, Agasa Ramu M, Debanjan S, Veerasamy R, Parasuraman P*. Potent Lead Identification for the Treatment of Depression: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[6] May 2023: 181-186.
  71. Brundha. S N, Soundarya G, Srinivas. G, Basavana G. H D, Agasa Ramu M, Veerasamy R, Debanjan S, Deepa R, Parasuraman P*. Evaluation of Potential Histamine H2 Receptor Antagonist: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[6] May 2023: 175-180.
  72. Srinivas G, Soundarya R, Basavanagowda H D, Brundha S N, Agasa Ramu M, Debanjan S, Veerasamy R, M Aynul Rifaya, Parasuraman P*. Identification of Lead Moiety to Inhibit Catechol-O-Methyl Transferase in the Treatment of Parkinson's Disease: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[6] May 2023: 168-174.
  73. Soundarya R, Basavana Gowda H D, Brunha S N, Srinivas G, Agasa Ramu M, Debanjan S, Veerasamy R, M Aynul Rifaya, Parasuraman P*. Discovering New Lead Moieties as ACE Inhibitors: A Computational Approach. Bull. Env. Pharmacol. Life Sci., Vol 12[6] May 2023: 161-167.
  74. Muniyandi Vijayalakshmi, Velmurugan Sundarapandian, Velayutham Siva Bharathi, Parasuraman Pavadai, et al. Graph theoretical network analysis and pharmacoinformatics-based investigation of bioactive compounds from Semecarpus anacardium Linn. for Alzheimer's disease. Journal of Computational Biophysics and Chemistry. (World Scientific Publishing - IF: 2.2). View Publication (DOI)
  75. Gopikrishna Gopakumar, Bhavani Ramesh, Drose Ignatious Shane Michaelson, Parasuraman Pavadai, et al. In silico analysis of phytocompounds from Aegle marmelos against potential targets of irritable bowel syndrome. Journal of Computational Biophysics and Chemistry. View Publication (DOI)
  76. Priya Petchimuthu, Chandu Ala, Selvaraj Kunjiappan, Parasuraman Pavadai, et al. Pharmacoinformatics-based identification of phytochemicals from Solanum torvum Swartz. fruits as potential inhibitors for MAPK14 protein. Journal of Biomolecular Structure and Dynamics. (Taylor and Francis - IF: 4.4). View Publication (DOI)
  77. Jaikanth Chandrasekaran, Pavadai Parasuraman*, Panneerselvam Theivendren, et al. Prospects for repurposing FDA-approved medications as Omicron spike/ACE-2 protein complex disruptors. J Res Pharm, 27(4): 1605-1614. (SCOPUS INDEXED). View Publication (DOI)
  78. Kirthi Bhushan A, Damodar Nayak Ammunje, Selvaraj Kunjiappan, Anbu Jayaraman, Manisha Devi, Parasuraman Pavadai*. An in-Silico approach to evaluate the binding efficacy and stability profile of MWCNT entangled rutin for breast cancer treatment. Nanomed. J. 10(3): 210-215. (SCOPUS INDEXED). View Publication (DOI)
  79. Senthilkumar Vellur, Parasuraman Pavadai, Sureshbabu Ram Kumar Pandian, et al. Optimization of ultrasound-assisted extraction of bioactive chemicals from Hemidesmus indicus (L.) R.Br. using response surface methodology and adaptive neuro-fuzzy inference system. Food Science and Biotechnology. (Springer Nature publisher - IF: 3.231). View Publication (DOI)
  80. Senthilkumar Vellur, Parasuraman Pavadai, Ewa Babkiewicz, et al. An in silico molecular modelling-based prediction of potential Keap1 inhibitors from Hemidesmus indicus (L) R.Br. against oxidative stress-induced diseases. Molecules, 28(11), 4541. (MDPI- IF: 4.927). View Publication (DOI)
  81. Anushree Chandrashekhar Gade, Manikanta Murahari, Parasuraman Pavadai, et al. Virtual Screening of a Marine Natural Product Database for In Silico Identification of a Potential Acetylcholinesterase Inhibitor. Life, 13(6), 1298. (MDPI- IF: 3.253). View Publication (DOI)
  82. Anjana Vidya Srivathsa, Nandini Markuli Sadashivappa, Apeksha K Hegde, et al., & Parasuraman Pavadai*. A review on Artificial Intelligence Approaches and Rational approaches in Drug Discovery. Current Pharmaceutical Design. (Bentham Science Publishers - IF: 3.31). View Publication (DOI)
  83. Madeswaran Arumugam, Brahmasundari Shanmugavel, Mohan Sellppan & Parasuraman Pavadai. In silico evaluation of some commercially available terpenoids as spike glycoprotein of SARS-CoV-2 – inhibitors using molecular dynamic approach. Journal of Biomolecular Structure and Dynamics. (Taylor and Francis - IF: 5.235). View Publication (DOI)
  84. Raja Rajeswari Rajeshkumar, Parasuraman Pavadai, Theivendren Panneerselvam, et al. Glucose-conjugated glutenin nanoparticles for selective targeting and delivery of camptothecin into breast cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology. (Springer Nature publisher - IF: 3.195). View Publication (DOI)
  85. Arjun Kumar Kalimuthu, Sureshbabu Ram Kumar Pandian, Parasuraman Pavadai, et al. Drug Delivery Applications of Exopolysaccharides from Endophytic Bacteria Pseudomonas otitidis from Tribulus terrestris L. Journal of Polymers and the Environment. (Springer Nature publisher - IF: 5.3). View Publication (DOI)
  86. Shanmugampillai Jeyarajaguru Kabilan, Selvaraj Kunjiappan, Krishnan Sundar, Parasuraman Pavadai, et al. Pharmacoinformatics-based screening of active compounds from Vitex negundo against lymphatic filariasis by targeting asparaginyl-tRNA synthetase. Journal of Molecular Modeling, 29:87. View Publication (DOI)
  87. R. Niranjana Devi, P. Pounraj, S Birendra Kumar, A. Saral, J. Kileyoba Vinnarasi, C. Vivek, P. Parasuraman, et al. Electronic, intermolecular, quantum computational investigations, molecular docking and simulation studies of the potent antiviral drug EIDD-2801. Journal of the Indian Chemical Society, 100(3): 100953. (Elsevier publisher - IF: 0.243). View Publication (DOI)
  88. Manisha Devi, G Chaitanya Sai, Damodar Nayak A, Parasuraman Pavadai, et al. Identification of Lead Moiety to Treat Polycystic Ovarian Syndrome from Ganoderma lucidum: A Computational Approach. Biointerface Research in Applied Chemistry, 13(5):1-20. (SCOPUS INDEXED). View Publication (DOI)
  89. Arjun Kumar Kalimuthu, Parasuraman Pavadai, Theivendren Panneerselvam, et al. Cytotoxic Potential of Bioactive Compounds from Aspergillus flavus, an Endophytic Fungus Isolated from Cynodon dactylon, against Breast Cancer: Experimental and Computational Approach. Molecules, 27:8814. (MDPI- IF: 4.927). View Publication (DOI)
  90. Nausheen Ahmed, R Deveswaran, P Parasuraman, et al. Topical delivery of natural extract for accelerated wound healing. Materials Today: Proceedings. (SCOPUS INDEXED). View Publication (DOI)
  91. Jaikanth Chandrasekaran, Senthilkumar Elumalai, Vidya Murugesan, Selvaraj Kunjiappan, Parasuraman Pavadai, et al. Computational design of PD-L1 small molecule inhibitors for cancer therapy. Molecular Diversity. View Publication (DOI)
  92. Prachita Gauns Dessai, Shivani Prabhu Dessai, Renuka Dabholkar, et al., & Parasuraman Pavadai, et al. Design, synthesis, graph theoretical analysis and molecular modelling studies of novel substituted quinoline analogues as promising anti-breast cancer agents. Molecular Diversity. View Publication (DOI)
  93. Palanichamy, Chandrasekar, Parasuraman Pavadai, Theivendren Panneerselvam, et al. Aphrodisiac Performance of Bioactive Compounds from Mimosa pudica Linn.: In Silico Molecular Docking and Dynamics Simulation Approach. Molecules, 27:3799. (MDPI- IF: 4.927). View Publication (DOI)
  94. Chaitra. R, Rohit Gandhi, Jayanna. N, Sachin Satyanath, Parasuraman Pavadai, et al. Computational Design of MmpL3 inhibitors for Tuberculosis Therapy. Molecular Diversity. View Publication (DOI)
  95. Jithya Suresh, Pushpalatha C, Parasuraman P, et al. An In-Silico Approach of the Antibacterial Activity of Coleus Amboinicus Against Streptococcus Mutans. ECS Transactions, 107(1): 18247-18254.
  96. Raja Rajeswari R, Banoth Karan Kumar, Pavadai Parasuraman, et al. Graph theoretical network analysis, in silico exploration and validation of bioactive compounds from Cynodon dactylon as potential neuroprotective agents against α-synuclein. BioImpacts, 12(6): 487-499. (Tabriz University of Medical Sciences - IF: 3.8). View Publication (DOI)
  97. Afraa Aqeel Zackria, Bala Mohan Sivani, Priyanka Venkatesh, Ramya Pattabiraman, S Birendra Kumar, Parasuraman P, et al. In silico screening of natural compounds from Curcuma amada Roxb for inhibition of Helicobacter pylori: Molecular docking, dynamics and ADMET studies. International Journal of Pharmaceutical Research, 14(1):124.
  98. Arjun Kumar K, Pavadai Parasuraman, Pandian Sivakumar, et al. In silico and in vitro screening of antioxidant and anticancer potentials of bioactive secondary metabolites from an endophytic fungus (Curvularia sp.) from Phyllanthus niruri L. Environmental Science and Pollution Research, 29(32):48908-48925. (Springer Nature publisher - IF: 5.19). View Publication (DOI)
  99. Arjun Kumar Kalimuthu, Theivendren Panneerselvam, Parasuraman Pavadai, et al. Pharmacoinformatics-based investigation of bioactive compounds of Rasam (South Indian recipe) against human cancer. Scientific Reports, 11:21488. (Nature Publisher - IF: 4.99). View Publication (DOI)
  100. Devanand Kamnoore, Dhrubojyoti Mukherjee, Damodar Nayak Ammunje, Pavadai Parasuraman, et al. Hydroxyapatite nanoparticle-enriched thiolated polymer-based biocompatible scaffold can improve skin tissue regeneration. Journal of Materials Research, 36; 4287–4306, 36; 4287-4306. (Springer Nature publisher - IF: 2.909). View Publication (DOI)
  101. Sureshbabu Ram Kumar Pandian, Selvaraj Kunjiappan, Parasuraman Pavadai, et al. Delivery of Ursolic Acid by Polyhydroxybutyrate Nanoparticles for Cancer Therapy: in silico and in vitro Studies. Drug Research, 72(2):72-81. View Publication (DOI)
  102. Rajagopal Gopalan, Nivetha Ambikapathi, Sundar Madasamy, et al., & Parasuraman Pavadai, et al. Mixed phytochemicals mediated synthesis of copper nanoparticles for anticancer and larvicidal applications. Heliyon, 7(6):e07360. (Elsevier- A Cell Press Journal- IF: 3.776). View Publication (DOI)
  103. Ram Kumar Pandian Sureshbabu, Theivendren Panneerselvam, Parasuraman Pavadai, et al. Nano based approach for the treatment of neglected tropical diseases. Frontiers in Nanotechnology, 3:49. (Frontiers Publisher). View Publication (DOI)
  104. Birendra Kumar, P. Parasuraman*, Krishna Murthy T P, et al. In silico screening of therapeutic potentials from Strychnos nux-vomica against the dimeric main protease (Mpro) structure of SARS-CoV-2. Journal of biomolecular structure & dynamics, 40(17):7796. (Taylor and Francis - IF: 5.235). View Publication (DOI)
  105. Ponnusamy P, Parasuraman P, Sankarganesh A, et al. Removal of water and their soluble materials from fuels using Moringa oleifera loaded keratin-co-sodium acrylate hydrogel. Journal of Porous Materials, 28:515–527.
  106. Selvaraj Kunjiappan, Murugesan Sankaranarayanan, Banoth Karan Kumar, Parasuraman Pavadai, et al. Capsaicin-loaded solid lipid nanoparticles: Design, biodistribution, in silico modeling and in vitro cytotoxicity evaluation. Nanotechnology, 32:095101. (IOP Publishers- IF: 3.953). View Publication (DOI)
  107. Ch. Jithendra, Saravanan G, Alagarsamy V, Panneerselvam T, Selvaraj K and Parasuraman P. Synthesis, Characterization & Antimicrobial Activities of New Isoxazole Substituted Mannich and Schiff Bases of 5-Nitroisatin Analogs. Asian Journal of Chemistry, 32(4);970. (SCOPUS INDEXED - IF: 0.13). View Publication (DOI)
  108. Sureshbabu Ram Kumar Pandian, Parasuraman Pavadai, Sivakumar Vellaisamy, et al. Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor. Naunyn-Schmiedeberg's Archives of Pharmacology, 394(4):735-749. (Springer Nature publisher - IF: 3.195). View Publication (DOI)
  109. Selvaraj Kunjiappan, Parasuraman Pavadai, Sivakumar Vellaichamy, et al. Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review. Drug Development Research, 1– 32, 1-. (Wiley online library- IF: 5.004). View Publication (DOI)
  110. Uma Priya Mohan, Bhaskaran Sriram, Theivendren Panneerselvam, et al., & Pavadai Parasuraman, et al. Utilization of plant-derived Myricetin molecule coupled with ultrasound for the synthesis of gold nanoparticles against breast cancer. Naunyn-Schmiedeberg's Archives of Pharmacology, 393, 1963–1976. (Springer Nature publisher - IF: 3.195). View Publication (DOI)
  111. Jithendar Reddy, Theivendren Panneerselvam, Pavadai Parasuraman. Design, In silico Modeling, Toxicity study and Synthesis of Novel Substituted Semicarbazide Derivatives of Pyrimidine: An Antitubercular Agent. Current Bioactive Compounds, 16(3): 294-301.
  112. Selvaraj Kunjiappan, Theivendren Panneerselvam, Saravanan Govindaraj, et al., & Pavadai Parasuraman, et al. “Optimization and analysis of ultrasound-assisted extraction of bioactive polyphenols from Garcinia indica using RSM and ANFIS modeling and its anticancer activity”. Journal of the Iranian Chemical Society, 17:789–801, 17:789-801. (Springer Publisher- IF: 2.271). View Publication (DOI)
  113. Suraj Baskararaj, Theivendren Panneerselvam, Saravanan Govindaraj, et al., & Pavadai Parasuraman, et al. “Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy”. 3 Biotech, 10:136. (Springer Nature publisher - IF: 2.893). View Publication (DOI)
  114. Selvaraj Kunjiappan, Saravanan Govindaraj, Pavadai Parasuraman, et al. “Design, insilico modelling and functionality theory of folate receptor targeted Myricetin -loaded bovine serum albumin nanoparticle formulation for cancer treatment”. Nanotechnology, 31(15):155102. (IOP Publishers - IF: 3.953). View Publication (DOI)
  115. Selvaraj Kunjiappan, Theivendren Panneerselvam, Parasuraman Pavadai, et al. "Design and Insilico Modelling of Indoloquinoxaline Incorporated Keratin Nanoparticles for modulation of Glucose metabolism in 3T3-L1 adipocytes". Biotechnology Progress, 36:e2904. (Wiley online library - IF: 2.909). View Publication (DOI)
  116. Pavadai Parasuraman*, Ramalingam Suresh, Panneerselvam Theivendren, et al. Synthesis of piperidine-4-one derivative containing dipeptides: An AChE and β-Secretase inhibitor. Anti-Infective Agents, 18(2):160-168.
  117. Theivendren Panneerselvam, Selvaraj Kunjiappan, Veerachamy Alagarsamy, Govindaraj Saravanan, and Pavadai Parasuraman. Design, Optimization, Synthesis and AntiTB Screening of Benzimidazole Derivatives. Anti-Infective Agents, 18(1):24-42.
  118. Selvaraj K, Panneerselvam T, Saravanan G, Parasuraman P, et al. Design, in silico modelling, and functionality theory of novel folate receptor targeted Rutin encapsulated folic acid conjugated keratin nanoparticles for effective cancer treatment. Anti-cancer Agents in Medicinal Chemistry, 19(16):1966-1982.
  119. Suraj B, Panneerselvam T, Ponnusamy P, et al., & Parasuraman P, et al. “Optimization of bioactive compounds extraction assisted by microwave parameters from Kappaphycus alvarezii using RSM and ANFIS modeling”. Journal of Food Measurement and Characterization, 13:2773–2789.
  120. Saravanan Govindaraj, Panneerselvam Theivendren, Kunjiappan Selvaraj, Parasuraman Pavadai, et al. Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2‐(methyl/phenyl) ‐3‐(4‐(5‐substituted‐1,3,4‐oxadiazol‐2‐yl) phenyl) quinazolin‐4(3H) ‐ones as NMDA receptor inhibitor. Drug Development Research, 80(3):368-385. (Wiley online library - IF: 5.004). View Publication (DOI)
  121. Selvaraj Kunjiappan, Panneerselvam Theivendren, Murugesan Sankaranarayanan, et al., & Pavadai Parasuraman, et al. Design, graph theoretical analysis and bioinformatic studies of proanthocyanidins encapsulated ethyl cellulose nanoparticles for effective anticancer activity. Biomedical Physics and Engineering Express, 5(2):025004. (IOP Publishers - IF: 0.33). View Publication (DOI)
  122. Panneerselvam Theivendren, Selvaraj Kunjiappan, Saravanan Govindraj, Jaikanth Chandrasekarn, Parasuraman Pavadai, et al. Graph Theoretical Analysis, Insilico Modeling and Formulation of Pyrimidine Nanoparticles as p38α MAP Kinases inhibitors: A Quantitative Proteomics Approach. Drug Research, 69(2):100-110.
  123. R. Deepa, M. S. Lakshmi, P. Parasuraman*, C. F. Sharon. “Design, Molecular Docking, Synthesis and Anti-fungal Activity of Novel Benzimidazole Derivatives”. Conference on Drug Design and Discovery Technologies 2019. (RSC Conference Proceedings, SCOPUS INDEXED). View Publication (DOI)
  124. A. Kalyani, Srinivasan Bharath, P. Parasuraman. “Molecular Docking Based Screening of “Nitrogen Containing Bisphosphonate Conjugate with Hydroxyapatite” Active Constituents Towards Mevalonate Pathway in Finding Potent Inhibitors for Anti-osteoporotic Activity”. Conference on Drug Design and Discovery Technologies 2019. (RSC Conference Proceedings, SCOPUS INDEXED). View Publication (DOI)
  125. Devanand Kamnoore, Dhrubojyoti Mukherjee, K. Bhagyashree, Debnath Shovik Kumar, Nayak Damodar, Pavadai Parsuraman. “Nanocomposite Hybrid Polymeric Scaffold for Skin Tissue Engineering”. Conference on Drug Design and Discovery Technologies 2019. (RSC Conference Proceedings, SCOPUS INDEXED). View Publication (DOI)
  126. Kunjiappan Selvaraj, Panneerselvam Theivendren, Somasundaram Balasubramanian, Sankaranarayanan Murugesan, Parasuraman Pavadai, et al. Design Graph Theoretical Analysis and In Silico Modeling of Dunaliella Bardawil Biomass Encapsulated N-Succinyl Chitosan Nanoparticles for Enhanced Anticancer Activity. Anti-Cancer Agents in Medicinal Chemistry, 18(13):1900-1918.
  127. Govindaraj Saravanan, Theivendren Panneerselvam, Veerachamy Alagarsamy, Pavadai Parasuraman, et al. Design, Graph Theoretical Analysis, Density Functionality Theories, Insilico Modeling, Synthesis, Characterization and Biological Activities of Novel Thiazole fused Quinazolinone Derivatives. Drug Development Research, 79(6):260-274. (Wiley online library - IF: 5.004). View Publication (DOI)
  128. Selvaraj Kunjiappan, Theivendran Panneerselvam, Balasubramanian Somasundaram, Sankarganesh Arunachalam, Murugesan Sankaranarayanan, Pavadai Parasuraman. Preparation of liposomes encapsulated Epirubicin-gold nanoparticles for Tumor specific delivery and release. Biomedical Physics and Engineering Express, 4(4):045027.
  129. Pandurangan Perumal, Lap Liew, Chun, Luong Ling, Yu, Hoi Tan, Ling, Pavadai Parasuraman. Docking studies on short and ultra-short peptides against beta-secretase (BACE1) enzyme. Drug Invention Today, 10(9): 1876-1880.
  130. Selvaraj Kunjiappan, Theivendren Panneerselvam, Parvathy Prasad, et al., & Pavadai Parasuraman. Design, graph theoretical analysis and in silico modeling of Dunaliella bardawil biomass encapsulated keratin nanoparticles: a scaffold for effective glucose utilization. Biomedical Materials, 13(4): 045012.
  131. P Parasuraman*, R.Suresh. Searching antiviral drugs for Ebola Virus from Phyto-constituents of Azadirachta indica: Application of molecular modelling studies. Asian Journal of Pharmaceutical and Clinical Research, 10 (7):254-257.
  132. Pavadai Parasuraman*, Ramalingam Suresh. Design and in silico molecular prediction of flavone-fused thiazole analogues as Acetyl Cholinesterase and β-Secretase inhibitor in the treatment of Alzheimer’s disease. International Journal of Pharm Tech Research, 7(1):125-131.
  133. Sandhirakasu Vembu, Pavadai Parasuraman, Mannathusamy Gopalakrishnan. Synthesis, in vitro antifungal and antitubercular evaluation of novel amino pyrimidines based tetrazole derivatives. Journal of Pharmacy Research, 8(10): 1552-1558.
  134. Pavadai Parasuraman*, Ramalingam Suresh, Dhanaraj Premnath. Balancing anti-amyloid and anti-cholinesterase capacity in a single chemical entity: in silico drug design. International Journal of Pharmacy and Pharmaceutical Sciences, 6(2): 571-574.
  135. Sandhirakasu Vembu, Pavadai Parasuraman, Mannathusamy Gopalakrishnan. Design, in silico molecular docking studies, synthesis, spectral characterization and in vitro antifungal evaluation of 1-(4-(1H-tetrazole-1-yl) phenyl)-3-arylprop-2-en-1-ones. Der Pharma Chemica, 6(5): 35-44.
  136. Pandurangan Perumal, Vijay Prakash Pandey, Pavadai Parasuraman. Docking studies on Antimicrobial Peptides related to Apidaecin-Ia and Human histatin against Glutamine synthetase and RNA polymerase in Mycobacterium tuberculosis. Asian Journal of Pharmaceutical and Clinical Research, 7(5): 195-201.
  137. Venkatesh P, Prakash G, Parasuraman P. Design, synthesis and cytotoxic activity of some novel flavones. International Journal of Pharmaceutical Sciences and Research, 3(2): 523-527.
  138. Nehru Krishna, M.Ganesan, L.Vengadassalapathy, Parasuraman P, Mathiazhagan.T. Guidance for Drug Accountability at CRO Site. Asian Journal of Pharmaceutical and Clinical Research, 5(2): 7-9.

Other International Publications

  1. Rajakumari.R, Vengadesh Prabu. K, Sundaramoorthi. C, Elsaid Taj Elsir Ahmed Elbaz, Parasuraman P. Stem cells in Current Treatment-Overview. International Journal of Institutional Pharmacy and Life Sciences, 3(2): 523-527.
  2. P. Mail Kumaran, V. Mangayarkarasi, P. Parasuraman, et al. Synthesis and Biological Evaluation of Hydrazone Derivatives. Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry, 1(2): 104-109.
  3. Pandurangan Perumal, Vijay Prakash Pandey, Pavadai Parasuraman. Docking Studies on Some Novel Piperidine Analogues against DNA Gyrase Enzyme. Inventi Impact: Molecular Modeling, 2014(2): 61-64.
  4. Parasuraman P*, Suresh R. Diverse aspect for discovering Anti-Alzheimer’s drug: A hypothesis. International Journal of Chemical and Pharmaceutical Sciences, 7 (4);71-74.
  5. Pandurangan Perumal, Pavadai Parasuraman, Vasudevan Mani, et al. Anticholinesterase Activity of Dipeptides: In-silico Docking and in-vitro Studies. Inventi Rapid: Molecular Modeling, 2017(2):1-4.
  6. Kalyani A, Bharath Srinivasan, Parasuraman Pavadai. In silico Pharmacological Screening of Nitrogen containing Bisphosphonate Conjugate with Hydroxyapatite. International Journal of Bone and Rheumatological Research, 5(1):77-84.
  7. Folitartha Roy, Kesha Desai, Parasuraman P, et al. A brief review on novel repurposing candidates for the treatment of myocardial infarction. International Journal of Engineering Applied Sciences and Technology, 5(10):140-143.

Book Chapters

  1. Raja Rajeswari Rajeshkumar, Jeganpandi Senthamarai Pandi, Murugesan Sankaranarayanan, Pavadai, P., Panneerselvam Theivendren, Selvaraj Kunjiappan. Cell Membrane Engineering for Advanced Drug Delivery Against Neurodegenerative and Inflammatory Diseases. In Cell Membrane Engineering for Advancing Cell-Based and Nanotechnology-Based Therapies. Springer Nature.
  2. Theivendren, P., Kunjiappan, S., Pavadai, P., et al. Success stories: impactful applications of cancer biomarkers. In The Potential of Cancer Biomarkers: From Discovery to Clinical Application. Elsevier Publication.
  3. Kunjiappan, S., Pandian, S. R. K., Theivendren, P., Pavadai, P., et al. Exploring the Role of Plant Secondary Metabolites for Aphrodisiacs. In Plant Specialized Metabolites: Phytochemistry, Ecology and Biotechnology. Springer Nature Book Chapter. View Publication (DOI)
  4. Kunjiappan, S., Theivendren, P., Pandian, S. R. K., Pavadai, P., et al. Nanoparticles for diagnosis and treatment of renal diseases. In Emerging Nanotechnologies for Medical Applications. Elsevier Book Chapter. View Publication (DOI)
  5. Sureshbabu RP, Vigneshwaran R, Panneerselvam T, Parasuraman P, et al. Nanomaterials for Cancer treatment. In Emerging Nanomaterials for Advanced Technologies. Springer Book Chapter. View Publication (DOI)
  6. Sundara Saravanan K, Selvam A, Selvaraj K, Parasuraman P, et al. Phytoconstituents as Lead Compounds for Anti-dengue Drug Discovery. In Antiviral Drug Discovery and Development. Springer Book Chapter.
  7. Pavadai Parasuraman*, Ramalingam Suresh, Mannathusamy Gopalakrishnan. A single chemical entity to balance Anti-Amyloid and Anti-Cholinesterase capacity: in silico drug design. In Nanobio Pharmaceutical Technology. ELSEVIER PUBLICATION.

NCBI Fungal Sequence Submissions

Characterized genetic sequences submitted to the National Center for Biotechnology Information (NCBI) GenBank:

Patents

  1. Pavadai, P., et al. Nanocomposite Functionalized Polymeric Scaffold for Skin Tissue. File number: 201941054263 (Granted: 27/12/2019)
  2. Pavadai, P., et al. 2-substituted benzylidene-4-phenyl-3a,4-dihydro-2h-thiazolo [3,2-a] quinazoline-1,5-dione. Application Number: 201741032775 (Published: 15/09/2017)
  3. Pavadai, P., et al. 2-Substituted Benzylidene-1-(2,2- Dimethylhydrazono)-4-Phenyl-3a,4-Dihydro-1H-Thiazolo[3,2-A] Quinazoline. Application Number: 201741040465 (Published: 13/11/2017)
  4. Pavadai, P., et al. 2-(3-(2-amino-1-iminoethyl) guanidino)-N-(4-substituted-(3-(phenylimino) -3,4-dihydroquinoxalin-2(1H)-ylidene) amino) phenyl) acetamide. Application Number: 201741044253 (Published: 08/12/2017)
  5. Pavadai, P., et al. Novel Dunaliella salina Formulation against Cardiovascular Complications. Application number: 202441032531 (Published: 24/04/2024)
  6. Pavadai, P., et al. Drug Entangled Multi-Walled Carbon Nanotubes Against Breast Cancer. Application Number: 202441043273 (Published: 24/04/2024)
  7. Pavadai, P., et al. Synthesis of 2-(2-(2-nitrophenyl)-1-phenylvinyl)-4-phenyl-5,6,7,8-tetrahydroquinazoline as PARP Inhibitors in Breast Cancer Treatment. Application No.202541021338 A (Published: 21/03/2025)